Log In
BCIQ
Print this Print this
 

PMR

  Manage Alerts
Collapse Summary General Information
Company Genovate Biotechnology Co. Ltd.
DescriptionOnce-daily cilostazol
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat intermittent claudication
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today